Inside Precision Medicine

  • Home
  • Inside Precision Medicine

Inside Precision Medicine Contact information, map and directions, contact form, opening hours, services, ratings, photos, videos and announcements from Inside Precision Medicine, Media/News Company, 140 Huguenot Street, .

Exclusive news, features, and analysis on the research, tools, regulations, and applications driving the future of precision medicine with the ultimate goal of transforming patient care and outcomes. Driven by a rapid and exponentially growing market – one that is expected to be valued at more than $126 billion by 2025 – and our commitment to covering the full breadth of the revolutionary field of

precision medicine, Clinical OMICs is now Inside Precision Medicine! Inside Precision Medicine is the only global media brand covering the full spectrum of precision medicine, taking a wide lens approach while bringing into sharp focus the many complex and interconnected issues that constitute the field. From our core areas of Translational Research, Molecular Diagnostics, Informatics, and Patient Care, to our expanded coverage of Disease Indications and Payer/Regulatory issues, our best-in-class content informs, educates, and enlightens our diverse audience of leading decision-makers.

AI Model Finds Gene Targets and Drug Combos to Reprogram Diseased CellsNovel AI neural network PDGrapher predicts therap...
10/09/2025

AI Model Finds Gene Targets and Drug Combos to Reprogram Diseased Cells

Novel AI neural network PDGrapher predicts therapeutic targets and drug intervention combos to restore cell health.

Harvard Medical School

Novel AI neural network PDGrapher predicts therapeutic targets and drug intervention combos to restore cell health.

Pre-Pregnancy CT Scans Raise Risk of Miscarriage, Fetal AbnormalitiesWomen who undergo CT scans before getting pregnant ...
10/09/2025

Pre-Pregnancy CT Scans Raise Risk of Miscarriage, Fetal Abnormalities

Women who undergo CT scans before getting pregnant are at increased risk for miscarriage and congenital abnormalities in their offspring.

McGill University

Women who undergo CT scans before getting pregnant are at increased risk for miscarriage and congenital abnormalities in their offspring.

Autism Genes Could Have Conferred Evolutionary BenefitThis discovery adds to theories that natural selection of specific...
10/09/2025

Autism Genes Could Have Conferred Evolutionary Benefit

This discovery adds to theories that natural selection of specific traits has increased the likelihood of certain disorders.

Stanford University

This discovery adds to theories that natural selection of specific traits has increased the likelihood of certain disorders.

Cartilage-Like Biomaterial Releases Arthritis Drugs in Response to Joint InflammationThe cartilage-like material reacts ...
10/09/2025

Cartilage-Like Biomaterial Releases Arthritis Drugs in Response to Joint Inflammation

The cartilage-like material reacts to changes in acidity that occur during inflammation by softening and releasing its therapeutic cargo.

University of Cambridge

The cartilage-like material reacts to changes in acidity that occur during inflammation by softening and releasing its therapeutic cargo.

Exposure to Air Pollution Linked to Alzheimer’s DiseaseHigher exposure to air pollution can lead to more severe Alzheime...
09/09/2025

Exposure to Air Pollution Linked to Alzheimer’s Disease

Higher exposure to air pollution can lead to more severe Alzheimer's disease symptoms and neuropathology, according to new research.

Perelman School of Medicine at the University of Pennsylvania, University of Pennsylvania

Higher exposure to air pollution can lead to more severe Alzheimer's disease symptoms and neuropathology, according to new research.

Menopausal Hot Flashes Eased Long-Term by Nonhormonal ElinzanetantMenopausal women received significant relief from mode...
09/09/2025

Menopausal Hot Flashes Eased Long-Term by Nonhormonal Elinzanetant

Menopausal women received significant relief from moderate or severe hot flashes when receiving oral, nonhormonal treatment with elinzanetant compared with placebo over the course of a year, the OASIS-3 trial has revealed.

Menopausal women received significant relief from moderate or severe hot flashes when receiving oral, nonhormonal treatment with elinzanetant compared with placebo over the course of a year, the OASIS-3 trial has revealed.

Blood-Based Alzheimer's Biomarkers Could Lead to Easier, Cheaper DiagnosticResearchers have discovered a link between se...
09/09/2025

Blood-Based Alzheimer's Biomarkers Could Lead to Easier, Cheaper Diagnostic

Researchers have discovered a link between self-reported cognitive decline and elevated levels of ptau-181, NfL, and GFAP found in the blood.

UC San Diego

Researchers have discovered a link between self-reported cognitive decline and elevated levels of ptau-181, NfL, and GFAP found in the blood.

Starving Glioblastoma: Diet-Based Treatment Shows PromiseLowering the levels of certain amino acids in the blood with a ...
09/09/2025

Starving Glioblastoma: Diet-Based Treatment Shows Promise

Lowering the levels of certain amino acids in the blood with a specialized diet may "starve" glioblastoma and support conventional treatments.

University of Michigan Rogel Cancer Center, University of Michigan

Lowering the levels of certain amino acids in the blood with a specialized diet may "starve" glioblastoma and support conventional treatments.

Portable Ultrasound Shortens Hospital Stays for Dyspnea PatientsPoint-of-care ultrasound devices could help doctors make...
08/09/2025

Portable Ultrasound Shortens Hospital Stays for Dyspnea Patients

Point-of-care ultrasound devices could help doctors make better diagnosis, leading to shorter hospital stays and lower hospitalization costs.

Rutgers Robert Wood Johnson Medical School - Piscataway, Robert Wood Johnson University Hospital

Point-of-care ultrasound devices could help doctors make better diagnosis, leading to shorter hospital stays and lower hospitalization costs.

Targeting ADAR1 in Glioblastoma Slows Tumor Growth and Reignites Immune ResponseADAR1 stalls the proliferation of gliobl...
08/09/2025

Targeting ADAR1 in Glioblastoma Slows Tumor Growth and Reignites Immune Response

ADAR1 stalls the proliferation of glioblastoma cells while simultaneously reprogramming the tumor microenvironment into an anti-tumoral state.

Luxembourg Institute of Health, Ludwig Cancer Research, Université de Lausanne

ADAR1 stalls the proliferation of glioblastoma cells while simultaneously reprogramming the tumor microenvironment into an anti-tumoral state.

Gene-Edited Pig Kidney Xenotransplants Get IND Clearance for Clinical TrialsPlus updates from eGenesis CEO Mike Curtis, ...
08/09/2025

Gene-Edited Pig Kidney Xenotransplants Get IND Clearance for Clinical Trials

Plus updates from eGenesis CEO Mike Curtis, PhD, on the dialysis-free progress of two patients with end-stage kidney disease that received xenotransplants.

Plus updates from eGenesis CEO Mike Curtis, PhD, on the dialysis-free progress of two patients with end-stage kidney disease that received xenotransplants.

BioNTech and DualityBio Score at Phase III with Breast Cancer TherapyBioNTech and Chinese partner DualityBio achieve pos...
08/09/2025

BioNTech and DualityBio Score at Phase III with Breast Cancer Therapy

BioNTech and Chinese partner DualityBio achieve positive Phase III results for the HER2 positive ADC they are developing, called trastuzumab pamirtecan, in patients with metastatic or inoperable disease.

BioNTech and DualityBio succeed at Phase III with trastuzumab pamirtecan in patients with metastatic or inoperable HER2 positive breast cancer.

Address

140 Huguenot Street

10801

Alerts

Be the first to know and let us send you an email when Inside Precision Medicine posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

  • Want your business to be the top-listed Media Company?

Share

About the Publication

Clinical OMICs is the leading source of practical insights for pathologists, clinicians, researchers, and scientists working to translate important findings across the broad range of “omics” technologies to deliver on the promise of molecular and precision medicine for patients.

Through a combination of industry news, features, and thoughtful analyses, Clinical OMICs emphasizes the practical—relevant knowledge and available tools—and empowers healthcare professionals to harness the application of molecular-based technologies and transform patient care. From sequencers and biomarkers to software and clinical decision support and everything in between, Clinical OMICs helps its readers stay current on the most critical research, tools, regulations, and applications affecting the practice of molecular pathology, the development of omics technologies and diagnostics, and the delivery of precision medicine.

Clinical OMICs provides readers with up-to-date content through its bimonthly Magazine, eNewsletters, and daily articles available on ClinicalOMICs.com.